Valeant Pharmaceuticals Chief Returns From Medical Leave
Sunday, February 28, 2016 - 23:40
in Biology & Nature
J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.
J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.